Skip to main content

Peer Review reports

From: EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates

Original Submission
1 Sep 2022 Submitted Original manuscript
12 Sep 2022 Author responded Author comments - Yunchuan Sun
Resubmission - Version 2
12 Sep 2022 Submitted Manuscript version 2
25 Sep 2022 Reviewed Reviewer Report
6 Nov 2022 Reviewed Reviewer Report
30 Nov 2022 Author responded Author comments - Yunchuan Sun
Resubmission - Version 3
30 Nov 2022 Submitted Manuscript version 3
3 Dec 2022 Author responded Author comments - Yunchuan Sun
Resubmission - Version 4
3 Dec 2022 Submitted Manuscript version 4
28 Dec 2022 Reviewed Reviewer Report
10 Jan 2023 Reviewed Reviewer Report
12 Mar 2023 Author responded Author comments - Yunchuan Sun
Resubmission - Version 5
12 Mar 2023 Submitted Manuscript version 5
20 Mar 2023 Author responded Author comments - Yunchuan Sun
Resubmission - Version 6
20 Mar 2023 Submitted Manuscript version 6
Publishing
4 Apr 2023 Editorially accepted
17 Apr 2023 Article published 10.1186/s12859-023-05271-7

You can find further information about peer review here.

Back to article page